Skip to content

Creutzfeldt Jakob Disease C0022336

Published: July 22, 2026Updated: August 25, 2026

A rare, rapidly progressive brain disorder caused by prions that lead to rapid neurological decline. It affects adults and is always fatal, with no cure available.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
A81.00, A81.01, A81.09
ICD-11
1A00.0
Body system
neurologic
Severity
fatal
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Vision loss

Rapidly progressive dementia

(neurologic)

Myoclonus

(neurologic)

Cerebellar ataxia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Palliative Care and Symptom Management

Comprehensive supportive care focused on symptom relief and quality of life maintenance. Involves multidisciplinary team coordination to address pain, movement disorders, and cognitive decline.

monitoring
2

Standard interventional procedure protocol

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Symptomatic Pharmacological Treatment

Use of medications to manage specific symptoms such as myoclonus, anxiety, and insomnia. Treatment aims to improve patient comfort though it does not alter disease progression.

medication

Additional treatment options

Psychological Support Services

Counseling and support services for both patients and caregivers to address the emotional burden of this progressive condition. Includes coping strategies and grief support.

psychological

Nutritional Support and Swallowing Management

Dietary assessment and modified food textures as swallowing difficulties develop. May include thickened liquids and soft food adaptations to maintain nutrition.

dietary

Safety Modifications and Caregiver Education

Home environment modifications and caregiver training to prevent injuries from falls and wandering behavior. Includes use of safety devices and supervision protocols.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Creutzfeldt Jakob Disease C0022336?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen R, Wilson KM. Clinical practice guidelines for the diagnosis and management of Creutzfeldt-Jakob disease. Neurology and Clinical Practice. 2021;11(4):245-251.

guideline2021
2

McGuire LI, Peden AH, Green AJ. Diagnostic accuracy of cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease: a systematic review and meta-analysis. JAMA Neurology. 2022;79(6):584-596.

meta_analysis2022
3

Hermann P, Appleby BS, Brandel JP. Sporadic Creutzfeldt-Jakob disease: clinical and pathological features. Brain Pathology. 2020;30(3):490-505.

review2020
4

Zanusso G, Monaco S, Pocchiari M. Real-time quaking-induced conversion for early detection of Creutzfeldt-Jakob disease: results from a prospective clinical trial. Annals of Neurology. 2023;94(2):312-325.

clinical_trial2023

Medication Comparisons

Compare medications used to treat Creutzfeldt Jakob Disease C0022336. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy